Invasive Hemodynamic Assessment in Heart Failure With Preserved Ejection Fraction

Invasive hemodynamic assessments served as the gold standard to quantify ventricular systolic and diastolic properties. Recently invasive hemodynamic assessment has been emerging as a robust approach to establish or refute heart failure with preserved ejection fraction (HFpEF) in the evaluation for unexplained dyspnea. Invasive catheterization also provides insights into the pathophysiologic mechanisms of patients with HFpEF and may allow more careful phenotyping to individualized therapy and hold promise to improve morbidity and mortality in the growing population of patients suffering from HFpEF.